Financhill
Back

Galderma Group AG 10K Form

Sell
30

GDERF
Galderma Group AG

Last Price:
$189.00
Seasonality Move:
31.76%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GDERF News And Ratings

See the #1 stock for the next 7 days that we like better than GDERF

GDERF Financial Statistics

Sales & Book Value

Annual Sales: $5.2B
Cash Flow: $0
Price / Cash Flow: 43.48
Annual Sales: $32.91
Price / Book: 4.86

Profitability

EPS (TTM): 2.58650
Net Income (TTM): $613M
Gross Margin: $3.6B
Return on Equity: 4.9%
Return on Assets: 2.98%

Galderma Group AG Earnings Forecast

Key Galderma Group AG Financial Ratios

  • The Gross Profit Margin over the past 5 years for GDERF is 68.66%.
  • The Selling, General & Administrative Expenses for GDERF have been equal to 47.78% of Gross Profit Margin.
  • The Research & Development expenses have been 4.71% of Revenue.
  • The Interest Expense is 24.63% of Operating Income.
  • The Net Earning history of GDERF is 11.77% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 4 years.

Galderma Group AG Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: GDERF
Website: galderma.com

Debt

Debt-to-Equity Ratio: 0.35
Current Ratio: 1.09
Quick Ratio: 0.8

Price-to-Earnings

Trailing P/E Ratio: 73.07
Forward P/E Ratio: 0

GDERF Technical Analysis vs Fundamental Analysis

Sell
30
Galderma Group AG (GDERF) is a Sell

Is Galderma Group AG a Buy or a Sell?